Cao, L., Song, H., Wu, G., Gui, H. M., Xu, Q., Wang, C., Fan, D., Feng, Y., Zhou, C., Ming, J., Wang, X., Wang, J., Ding, M., Wu, Y., Zhong, L., Ding, K. (2025). Orelabrutinib combined with short-course bendamustine-rituximab (BR) for first-line treatment of chronic lymphocytic leukemia: A prospective multicenter study. Blood. https://doi.org/10.1182/blood-2025-2127